Altimmune, Inc.ALTNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank14
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-89.46M
↓ 45% vs avg
Percentile
P14
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-61.88M
Historical baseline
PeriodValueYoY Change
TTM$-89.46M+5.6%
2024$-94.81M-7.8%
2023$-87.94M-4.2%
2022$-84.41M+12.6%
2021$-96.53M-153.3%
2020$-38.10M-88.7%
2019$-20.19M+54.9%
2018$-44.72M+13.6%
2017$-51.76M-374.3%
2016$-10.91M-